NCT03238742View on ClinicalTrials.gov

The Efficacy of Xuebijing Injection on Sepsis

PHASE4CompletedINTERVENTIONAL
Enrollment

1,817

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

July 28, 2019

Study Completion Date

January 8, 2020

Conditions
Sepsis
Interventions
DRUG

Xuebijing Injection

100ml Xuebijing Injection every 12 hours for 5 days

DRUG

normal saline

200ml normal saline every 12 hours for 5 days

Trial Locations (1)

210009

Zhongda Hospital, Nanjing

All Listed Sponsors
collaborator

National Health and Family Planning Commission, P.R.China

OTHER_GOV

lead

Southeast University, China

OTHER

NCT03238742 - The Efficacy of Xuebijing Injection on Sepsis | Biotech Hunter | Biotech Hunter